The role of oligomerization for the biological functions of the arenavirus nucleoprotein

Archives of Virology

Volumn 158, Issue 9, 2013, Pages 1895-1905

  Lennartz, Frank ^a   Hoenen, Thomas ^a,b   Lehmann, Maria ^c   Groseth, Allison ^a,b   Garten, Wolfgang ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOPROTEIN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARENAVIRUS; ARTICLE; CELL STRAIN HEK293; CHEMISTRY; GENETICS; HUMAN; LASSA VIRUS; METABOLISM; MOLECULAR GENETICS; PROTEIN MULTIMERIZATION; TUMOR CELL LINE; VIRUS REPLICATION;

AMINO ACID SEQUENCE; ARENAVIRUS; CELL LINE, TUMOR; HEK293 CELLS; HUMANS; LASSA VIRUS; MOLECULAR SEQUENCE DATA; NUCLEOPROTEINS; PROTEIN MULTIMERIZATION; VIRAL PROTEINS; VIRUS REPLICATION;

ARENAVIRUS; LASSA VIRUS; MAMMALIA;

EID: 84883281525     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-013-1684-9     Document Type: Article

References (36)

1. Agnihothram S, Dancho B, Grant K, Grimes M, Lyles D, Nunberg J (2009) Assembly of arenavirus envelope glycoprotein GPC in detergent-soluble membrane microdomains. J Virol 83: 9890-10790.
2. Basler CF, Wang X, Mühlberger E, Volchkov V, Paragas J, Klenk HD, Garcia-Sastre A, Palese P (2000) The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci USA 97: 12289-12294.
3. Brunotte L, Kerber R, Shang W, Hauer F, Hass M, Gabriel M, Lelke M, Busch C, Stark H, Svergun DI, Betzel C, Perbandt M, Günther S (2011) Structure of the Lassa virus nucleoprotein revealed by X-ray crystallography, small-angle X-ray scattering, and electron microscopy. J Biol Chem 286: 38748-38756.
4. Buchholz UJ, Finke S, Conzelmann KK (1999) Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J Virol 73: 251-259.
5. Buchmeier MJ, De La Torre JC, Peters CJ (2007) Arenaviridae: the viruses and their replication. In: Knipe DM, Howley PM (eds) Fields virology. Lippincott Williams & Wilkins, pp 1791-1828.
6. Casabona JC, Levingston Macleod JM, Loureiro ME, Gomez GA, Lopez N (2009) The RING domain and the L79 residue of Z protein are involved in both the rescue of nucleocapsids and the incorporation of glycoproteins into infectious chimeric arenavirus-like particles. J Virol 83: 7029-7039.
7. Clegg J (1992) Current progress towards vaccines for arenavirus-caused diseases. Vaccine 10: 89-184.
8. DiCarlo A, Möller P, Lander A, Kolesnikova L, Becker S (2007) Nucleocapsid formation and RNA synthesis of Marburg virus is dependent on two coiled coil motifs in the nucleoprotein. Virol J 4: 105.
9. Eichler R, Strecker T, Kolesnikova L, ter Meulen J, Weissenhorn W, Becker S, Klenk HD, Garten W, Lenz O (2004) Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP). Virus Res 100: 249-255.
10. Geisbert TW, Jones S, Fritz EA, Shurtleff AC, Geisbert JB, Liebscher R, Grolla A, Ströher U, Fernando L, Daddario KM, Guttieri MC, Mothe BR, Larsen T, Hensley LE, Jahrling PB, Feldmann H (2005) Development of a new vaccine for the prevention of Lassa fever. PLoS Med 2: e183.
11. Groseth A, Wolff S, Strecker T, Hoenen T, Becker S (2010) Efficient budding of the tacaribe virus matrix protein z requires the nucleoprotein. J Virol 84: 3603-3611.
12. Günther S, Lenz O (2004) Lassa virus. Critical reviews in clinical laboratory sciences 41: 339-429.
13. Hass M, Golnitz U, Müller S, Becker-Ziaja B, Günther S (2004) Replicon system for Lassa virus. J Virol 78: 13793-13803.
14. Hastie K, Kimberlin C, Zandonatti M, MacRae I, Saphire E (2011) Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppression. Proc Natl Acad Sci USA 108: 2396-2797.
15. Hastie KM, Liu T, Li S, King LB, Ngo N, Zandonatti MA, Woods VL Jr, de la Torre JC, Saphire EO (2011) Crystal structure of the Lassa virus nucleoprotein-RNA complex reveals a gating mechanism for RNA binding. Proc Natl Acad Sci USA 108: 19365-19370.
16. Jacamo R, Lopez N, Wilda M, Franze-Fernandez MT (2003) Tacaribe virus Z protein interacts with the L polymerase protein to inhibit viral RNA synthesis. J Virol 77: 10383-10393.
17. Jiang X, Dalebout TJ, Bredenbeek PJ, Carrion R Jr, Brasky K, Patterson J, Goicochea M, Bryant J, Salvato MS, Lukashevich IS (2011) Yellow fever 17D-vectored vaccines expressing Lassa virus GP1 and GP2 glycoproteins provide protection against fatal disease in guinea pigs. Vaccine 29: 1248-1257.
18. Kerber R, Rieger T, Busch C, Flatz L, Pinschewer DD, Kummerer BM, Günther S (2011) Cross-species analysis of the replication complex of old world arenaviruses reveals two nucleoprotein sites involved in L protein function. J Virol 85: 12518-12528.
19. Kimberlin CR, Bornholdt ZA, Li S, Woods VL Jr, MacRae IJ, Saphire EO (2010) Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression. Proc Natl Acad Sci USA 107: 314-319.
20. Lee KJ, Novella IS, Teng MN, Oldstone MB, de La Torre JC (2000) NP and L proteins of lymphocytic choriomeningitis virus (LCMV) are sufficient for efficient transcription and replication of LCMV genomic RNA analogs. J Virol 74: 3470-3477.
21. Levingston Macleod JM, D'Antuono A, Loureiro ME, Casabona JC, Gomez GA, Lopez N (2011) Identification of two functional domains within the arenavirus nucleoprotein. J Virol 85: 2012-2023.
22. Lopez N, Jacamo R, Franze-Fernandez MT (2001) Transcription and RNA replication of tacaribe virus genome and antigenome analogs require N and L proteins: Z protein is an inhibitor of these processes. J Virol 75: 12241-12251.
23. Martinez-Sobrido L, Giannakas P, Cubitt B, Garcia-Sastre A, de la Torre JC (2007) Differential inhibition of type I interferon induction by arenavirus nucleoproteins. J Virol 81: 12696-12703.
24. Ortiz-Riano E, Cheng BY, de la Torre JC, Martinez-Sobrido L (2011) The C-terminal region of lymphocytic choriomeningitis virus nucleoprotein contains distinct and segregable functional domains involved in NP-Z interaction and counteraction of the type I interferon response. J Virol 85: 13038-13048.
25. Ortiz-Riano E, Cheng BY, de la Torre JC, Martinez-Sobrido L (2012) Self-association of lymphocytic choriomeningitis virus nucleoprotein is mediated by its N-terminal region and is not required for its anti-interferon function. J Virol 86: 3307-3317.
26. Ortiz-Riano E, Cheng BY, de la Torre JC, Martinez-Sobrido L (2012) D471G mutation in LCMV-NP affects its ability to self-associate and results in a dominant negative effect in viral RNA synthesis. Viruses 4: 2137-2161.
27. Pinschewer D, Perez M, de la Torre J (2003) Role of the virus nucleoprotein in the regulation of lymphocytic choriomeningitis virus transcription and RNA replication. J Virol 77: 3882-3889.
28. Qi X, Lan S, Wang W, Schelde L, Dong H, Wallat G, Ly H, Liang Y, Dong C (2010) Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature 468: 779-862.
29. Reid SP, Cardenas WB, Basler CF (2005) Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein. Virology 341: 179-189.
30. Ruigrok RW, Crepin T, Kolakofsky D (2011) Nucleoproteins and nucleocapsids of negative-strand RNA viruses. Curr Opin Microbiol 14: 504-510.
31. Schlie K, Maisa A, Freiberg F, Groseth A, Strecker T, Garten W (2010) Viral protein determinants of Lassa virus entry and release from polarized epithelial cells. J Virol 84: 3178-3188.
32. Schlie K, Maisa A, Lennartz F, Ströher U, Garten W, Strecker T (2010) Characterization of Lassa virus glycoprotein oligomerization and influence of cholesterol on virus replication. J Virol 84: 983-992.
33. Shtanko O, Imai M, Goto H, Lukashevich IS, Neumann G, Watanabe T, Kawaoka Y (2010) A role for the C terminus of Mopeia virus nucleoprotein in its incorporation into Z protein-induced virus-like particles. J Virol 84: 5415-5422.
34. Strecker T, Eichler R, Meulen J, Weissenhorn W, Klenk HD, Garten W, Lenz O (2003) Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected]. J Virol 77: 10700-10705.
35. Sutter G, Ohlmann M, Erfle V (1995) Non-replicating vaccinia vector efficiently expresses bacteriophage T7 RNA polymerase. FEBS Lett 371: 9-12.
36. Ye Q, Krug RM, Tao YJ (2006) The mechanism by which influenza A virus nucleoprotein forms oligomers and binds RNA. Nature 444: 1078-1082.